Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ReviveMed
AddedFeb 15, 2024
UpdatedJun 18, 2026
ReviveMed

ReviveMed

Seed

AI-driven biotech start-up specializing in metabolomic data analysis.

HQ
Cambridge, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees

ReviveMed is an AI-driven biotech start-up specializing in metabolomic data analysis. The company leverages artificial intelligence to interpret complex metabolomic data, aiming to accelerate drug discovery and development. Their market focus includes pharmaceutical companies and healthcare providers seeking advanced solutions for metabolic disorders and other health conditions.

ReviveMed has made significant strides in the biotech industry, partnering with leading pharmaceutical firms to enhance drug development processes. The company's innovative approach has garnered attention and investment from prominent venture capitalists, contributing to its rapid growth and impact in the field of precision medicine.

ReviveMed - Similar Companies

RevivBio logo

RevivBio

revivbio.com

Re-vive logo

Re-vive

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Revive Biotechnology logo

Revive Biotechnology

revivebiotech.com

Rejuvitas logo

Rejuvitas

rejuvitas.com

Revvity logo

Revvity

Matterworks logo

Matterworks

matterworksbio.com

Metanovas Biotech logo

Metanovas Biotech

metanovas.com

Vibe Bio logo

Vibe Bio

vibebio.com

Medeloop logo

Medeloop

medeloop.ai

Convalesce logo

Convalesce

convalesce.co

NuMedii logo

NuMedii

numedii.com

Biomiic logo

Biomiic

Revagenix logo

Revagenix

revagenix.com

Intellimedix logo

Intellimedix

ReviveMed - Quick Facts

Who are ReviveMed's competitors?

Companies similar to ReviveMed include RevivBio, Re-vive, Regenerative Bio and Revive Biotechnology.

When was ReviveMed founded?

ReviveMed was founded in 2016.

Where is ReviveMed's headquarters located?

ReviveMed's headquarters is located in Cambridge, MA, US.

How much has ReviveMed raised to-date?

As of Jul 13, 2022, ReviveMed has raised a total of $1.7M (USD).

How many employees does ReviveMed have?

ReviveMed has 7 employees as of Feb 5, 2024.

ReviveMed - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Data Analysis
Tags
  • AI Operations
  • Biotech
  • Data Information
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 9 more industry codes
NAICS
  • 518000Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 518200Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 518210Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services